Bone Marrow-derived Dendritic Cell (BMDC) Preparation
3:25
T Cell Syngeneic Proliferation Assay
7:26
Results: Representative Tolerogenic DC (TolDC) Analyses
8:53
Conclusion
文字起こし
The overall goal of this protocol is to develop and characterize murine tolerogenic dendritic cells for the evaluation of their immunotherapeutic utility in the treatment of autoimmune disorders, such as multiple sclerosis. This method can help an
このコンテンツにアクセスするにはサインインするか無料トライアルを開始してください
Here, we present a protocol to develop and characterize tolerogenic dendritic cells (TolDCs) and evaluate their immunotherapeutic utility.